Implementing a program for switching from i.v. to oral antimicrobial therapy

American Journal of Health-System Pharmacy

Volumn 58, Issue 12, 2001, Pages 1146-1149

  Wong Beringer, A ^a   Nguyen, K H ^a   Razeghi, J ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ALGORITHM; ARTICLE; CLINICAL PHARMACY; COST CONTROL; DRUG COST; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITAL PHARMACY; PHARMACEUTICAL CARE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; TREATMENT PLANNING; UNITED STATES;

EID: 0035876195     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.12.1146     Document Type: Article

References (14)

1. Early switch from intravenous to oral antibiotics and early hospital discharge: A prospective observational study of 200 consecutive patients with community- acquired pneumonia
2. Evaluation of the use of cefuroxime and cefuroxime axetil in an intravenous- oral step-down program
3. Early switch from intravenous to oral antibiotics: Guidelines and implementation in a large teaching hospital
4. A pharmacist-initiated program of intravenous to oral antibiotic conversion
5. Duration and route of antibiotic therapy in community-acquired pneumonia: Switch and step-down therapy
6. Comparative clinical, microbiologic, and economic audit of the use of oral ciprofloxacin and parenteral antimicrobials
7. Intravenous-to-oral stepdown program: Four years of experience in a large teaching hospital
8. Identification of low-risk hospitalized patients with pneumonia: Implications for early conversion to oral antimicrobial therapy
9. Pharmacoeconomic benefit of antibiotic step-down therapy: Converting patients from intravenous ceftriaxone to oral cefpodoxime proxetil
10. A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions
11. A prospective randomized study of inpatient IV antibiotics for community-acquired pneumonia: The optimal duration of therapy
12. Physician manipulation of reimbursement rules for patients. Between a rock and a hard place